Yingzi Cui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yingzi Cui has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- George Fu Gao
Strategic Pandemic Preparedness Action and Research Center (SPARC), Guangzhou National Laboratory
2 shared publications Benkun Qi
1 shared publication- Dehai Li
Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China
1 shared publication - Guangyuan Luo
Key Laboratory of Marine Drugs Ministry of Education, School of Medicine and Pharmacy, Sanya Oceanographic Institution, Ocean University of China, Qingdao 266003, China
1 shared publication - Hailan Yao
Department of Biochemistry and Immunology, Capital Center for Children’s Health, Capital Medical University, Capital Institute of Pediatrics, China
1 shared publication - Hailan Yao
Capital Institute of Pediatrics-Peking University Teaching Hospital, Beijing 100020, China
1 shared publication
Latest Publications
- Open Access
- 2 November 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (11) , 2513
The Chiral Isomers of Chlorogenic Acid Exert Distinct Antiviral Effects on Coxsackievirus A16 Infection
Coxsackievirus A16 (CVA16) is one of the major pathogens responsible for hand, foot, and mouth disease (HFMD), for which no specific antiviral therapy is currently available. Neochlorogenic acid (NCGA) and chlorogenic acid (CGA) are a pair of chiral isomers with highly similar chemical structures. While the antiviral activity of CGA has been extensively investigated, that of NCGA remains largely unexplored. In our study, we found that NCGA exhibited antiviral activity against CVA16, whereas CGA was completely inactive. Notably, NCGA also displayed extremely low cytotoxicity, and its antiviral efficacy was further confirmed in vivo. We further identified RNA-binding motif protein 24 (RBM24) as a host factor involved in the antiviral effect of NCGA against CVA16, as its knockdown attenuated the antiviral activity of NCGA. Collectively, our findings not only identify a novel natural product against CVA16 but also provide clues for the discovery of host factors involved in CVA16 infection.
- 2 November 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (11) , 2513
Open AccessThe Chiral Isomers of Chlorogenic Acid Exert Distinct Antiviral Effects on Coxsackievirus A16 Infection
Coxsackievirus A16 (CVA16) is one of the major pathogens responsible for hand, foot, and mouth disease (HFMD), for which no specific antiviral therapy is currently available. Neochlorogenic acid (NCGA) and chlorogenic acid (CGA) are a pair of chiral isomers with highly similar chemical structures. While the antiviral activity of CGA has been extensively investigated, that of NCGA remains largely unexplored. In our study, we found that NCGA exhibited antiviral activity against CVA16, whereas CGA was completely inactive. Notably, NCGA also displayed extremely low cytotoxicity, and its antiviral efficacy was further confirmed in vivo. We further identified RNA-binding motif protein 24 (RBM24) as a host factor involved in the antiviral effect of NCGA against CVA16, as its knockdown attenuated the antiviral activity of NCGA. Collectively, our findings not only identify a novel natural product against CVA16 but also provide clues for the discovery of host factors involved in CVA16 infection.
- Open Access
- 23 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 9460
Reporter Virus-Based High-Throughput Screening Identifies LM-10 as a Novel Inhibitor Targeting KRM1 for Coxsackievirus A10 Blockade
Enteroviruses causing hand, foot, and mouth disease, including currently circulating Coxsackievirus A10 (CVA10) and Coxsackievirus A6 (CVA6), rely on KREMEN1 (KRM1) for cell entry, making the virus–KRM1 interface a potential target for antiviral intervention. We screened GLMarNP, an in-house library of about 3000 natural products and derivatives. Candidates targeting the KRM1 ectodomain were selected by blind docking, drug-likeness assessment, and scaffold diversity analysis. To enable high-throughput antiviral screening, we inserted eGFP into a full-length infectious CVA10 cDNA clone to generate a reporter virus designated eGFP-A10. The virus was rescued in HEK293T cells and produced robust fluorescence in RD cells over serial passages. Among 29 candidate compounds, LM-10 showed the strongest antiviral activity and exhibited low cytotoxicity. Mechanistically, LM-10 bound KRM1 and acted early in the viral life cycle. Molecular docking suggested that LM-10 binds the KR domain at a site overlapping the VP2 EF-loop contact region. KRM1 also acts as a DKK1 receptor to regulate Wnt/β-catenin signaling. LM-10 did not significantly affect this pathway in the TOP-GFP reporter assay or in transgenic zebrafish embryos. These findings establish a practical CVA10 reporter-virus platform and support steric blockade of the receptor interface as a potential antiviral strategy.
- 23 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 9460
Open AccessReporter Virus-Based High-Throughput Screening Identifies LM-10 as a Novel Inhibitor Targeting KRM1 for Coxsackievirus A10 Blockade
Enteroviruses causing hand, foot, and mouth disease, including currently circulating Coxsackievirus A10 (CVA10) and Coxsackievirus A6 (CVA6), rely on KREMEN1 (KRM1) for cell entry, making the virus–KRM1 interface a potential target for antiviral intervention. We screened GLMarNP, an in-house library of about 3000 natural products and derivatives. Candidates targeting the KRM1 ectodomain were selected by blind docking, drug-likeness assessment, and scaffold diversity analysis. To enable high-throughput antiviral screening, we inserted eGFP into a full-length infectious CVA10 cDNA clone to generate a reporter virus designated eGFP-A10. The virus was rescued in HEK293T cells and produced robust fluorescence in RD cells over serial passages. Among 29 candidate compounds, LM-10 showed the strongest antiviral activity and exhibited low cytotoxicity. Mechanistically, LM-10 bound KRM1 and acted early in the viral life cycle. Molecular docking suggested that LM-10 binds the KR domain at a site overlapping the VP2 EF-loop contact region. KRM1 also acts as a DKK1 receptor to regulate Wnt/β-catenin signaling. LM-10 did not significantly affect this pathway in the TOP-GFP reporter assay or in transgenic zebrafish embryos. These findings establish a practical CVA10 reporter-virus platform and support steric blockade of the receptor interface as a potential antiviral strategy.
- 17 February 2026
- Published by Elsevier in Journal of Clinical Virology
- Vol. 183, 105928
Virus-induced onychomadesis: Exploring the role of viral infection in nail shedding
- 17 February 2026
- Published by Elsevier in Journal of Clinical Virology
- Vol. 183, 105928
Virus-induced onychomadesis: Exploring the role of viral infection in nail shedding
- Open Access
- 1 January 2025
- Published by KEAI Publishing in Advanced Membranes
- Vol. 5
Membrane technology for sterilization and virus elimination of biopharmaceuticals: Fouling matters
- 1 January 2025
- Published by KEAI Publishing in Advanced Membranes
- Vol. 5
Open AccessMembrane technology for sterilization and virus elimination of biopharmaceuticals: Fouling matters
- Open Access
- 5 June 2024
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 221 (8)
Coxsackievirus A10 impairs nail regeneration and induces onychomadesis by mimicking DKK1 to attenuate Wnt signaling
Coxsackievirus A10 (CV-A10) infection, a prominent cause of childhood hand-foot-and-mouth disease (HFMD), frequently manifests with the intriguing phenomenon of onychomadesis, characterized by nail shedding. However, the underlying mechanism is elusive. Here, we found that CV-A10 infection in mice could suppress Wnt/β-catenin signaling by restraining LDL receptor–related protein 6 (LRP6) phosphorylation and β-catenin accumulation and lead to onychomadesis. Mechanistically, CV-A10 mimics Dickkopf-related protein 1 (DKK1) to interact with Kringle-containing transmembrane protein 1 (KRM1), the CV-A10 cellular receptor. We further found that Wnt agonist (GSK3β inhibitor) CHIR99021 can restore nail stem cell differentiation and protect against nail shedding. These findings provide novel insights into the pathogenesis of CV-A10 and related viruses in onychomadesis and guide prognosis assessment and clinical treatment of the disease.
- 5 June 2024
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 221 (8)
Open AccessCoxsackievirus A10 impairs nail regeneration and induces onychomadesis by mimicking DKK1 to attenuate Wnt signaling
Coxsackievirus A10 (CV-A10) infection, a prominent cause of childhood hand-foot-and-mouth disease (HFMD), frequently manifests with the intriguing phenomenon of onychomadesis, characterized by nail shedding. However, the underlying mechanism is elusive. Here, we found that CV-A10 infection in mice could suppress Wnt/β-catenin signaling by restraining LDL receptor–related protein 6 (LRP6) phosphorylation and β-catenin accumulation and lead to onychomadesis. Mechanistically, CV-A10 mimics Dickkopf-related protein 1 (DKK1) to interact with Kringle-containing transmembrane protein 1 (KRM1), the CV-A10 cellular receptor. We further found that Wnt agonist (GSK3β inhibitor) CHIR99021 can restore nail stem cell differentiation and protect against nail shedding. These findings provide novel insights into the pathogenesis of CV-A10 and related viruses in onychomadesis and guide prognosis assessment and clinical treatment of the disease.